<DOC>
	<DOCNO>NCT02823730</DOCNO>
	<brief_summary>To compare incidence major adverse cardiac event among series patient receive Synergy drug-eluting stent bioabsorbable polymer historical control receive Promus Premier drug-eluting stent durable polymer .</brief_summary>
	<brief_title>Registry Experience Washington Hospital Center With Drug Eluting Stents - Synergy</brief_title>
	<detailed_description>The primary objective observational , real-world single-center registry compare incidence major adverse cardiac event among series patient receive Synergy drug-eluting stent bioabsorbable polymer historical control receive Promus Premier drug-eluting stent durable polymer . The investigator hypothesize long-term incidence ( year follow implantation , 4 year ) major adverse cardiovascular event , propensity match stent type , similar Synergy Xience V .</detailed_description>
	<criteria>1 . Subject &gt; 18 year age 2 . Underwent PCI Synergy ( alone ) DES 1 . Underwent PCI nonSynergy DES ( scaffold ) index procedure 2 . Patients take , unable take , dual antiplatelet therapy ( DAPT ) time screen study ( patient discontinue DAPT enrollment include )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>